{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:36:51Z","timestamp":1790422611077,"version":"4.1.0"},"reference-count":105,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3314\/mmj.18.004","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T22:35:55Z","timestamp":1527719755000},"page":"E31-E40","source":"Crossref","is-referenced-by-count":27,"title":["Role of <I>FKS<\/I> Gene in the Susceptibility of Pathogenic Fungi to Echinocandins"],"prefix":"10.3314","volume":"59","author":[{"given":"Yasuhiro","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, Toho University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Denning DW: Echinocandin antifungal drugs. Lancet 362: 1142-1151, 2003.","DOI":"10.1016\/S0140-6736(03)14472-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chen SC, Slavin MA, Sorrell TC: Echinocandin antifungal drugs in fungal infections: a comparison. Drugs 71: 11-41, 2011.","DOI":"10.2165\/11585270-000000000-00000"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Davis SL, Vazquez JA: Anidulafungin: an evidence-based review of its use in invasive fungal infections. Core Evid 2: 241-249, 2008.","DOI":"10.2147\/CE.S7433"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Glöckner A: Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin: review of the literature. Eur J Med Res 16: 167-179, 2011.","DOI":"10.1186\/2047-783X-16-4-167"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Heinz WJ, Buchheidt D, Ullmann AJ: Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus<\/I> infections. Mycoses 59: 480-493, 2016.","DOI":"10.1111\/myc.12477"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) de la Torre P, Reboli AC: Micafungin: an evidence-based review of its place in therapy. Core Evid 9: 27-39, 2014.","DOI":"10.2147\/CE.S36304"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Enoch DA, Idris SF, Aliyu SH, Micallef C, Sule O, Karas JA: Micafungin for the treatment of invasive aspergillosis. J Infect 68: 507-526, 2014.","DOI":"10.1016\/j.jinf.2014.01.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Izumikawa K, Tashiro M, Kohno S: Management of chronic pulmonary aspergillosis. Ann N Y Acad Sci 1272: 40-48, 2012.","DOI":"10.1111\/j.1749-6632.2012.06758.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62: e1-e50, 2016.","DOI":"10.1093\/cid\/civ1194"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cornely OA, Bassetti M, Calandra T, et al; ESCMID Fungal Infection Study Group: ESCMID∗<\/sup> guideline for the diagnosis and management of Candida<\/I> diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18 (Suppl 7): 19-37, 2012.","DOI":"10.1111\/1469-0691.12039"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ullmann AJ, Akova M, Herbrecht R, et al; ESCMID Fungal Infection Study Group: ESCMID∗<\/sup> guideline for the diagnosis and management of Candida<\/I> diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 18 (Suppl 7): 53-67, 2012.","DOI":"10.1111\/1469-0691.12041"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Kohno S, Tamura K, Niki Y, et al: Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014. Med Mycol J 57: E117-E163, 2016.","DOI":"10.3314\/mmj.16-00010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Miyazaki T, Kohno S: Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis. Expert Rev Anti Infect Ther 13: 1171-1183, 2015.","DOI":"10.1586\/14787210.2015.1058157"},{"key":"14","doi-asserted-by":"crossref","unstructured":"16) Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM: Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 55: 1352-1361, 2012.","DOI":"10.1093\/cid\/cis697"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17) Arendrup MC, Perlin DS: Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27: 484-492, 2014.","DOI":"10.1097\/QCO.0000000000000111"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18) Douglas CM: Fungal beta(1,3)-D-glucan synthesis. Med Mycol 39 (Suppl 1): 55-66, 2001.","DOI":"10.1080\/mmy.39.1.55.66"},{"key":"17","doi-asserted-by":"crossref","unstructured":"19) Hatano K, Morishita Y, Nakai T, Ikeda F: Antifungal mechanism of FK463 against Candida albicans<\/I> and Aspergillus fumigatus<\/I>. J Antibiot (Tokyo) 55: 219-222, 2002.","DOI":"10.7164\/antibiotics.55.219"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20) Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM, Smith JG, Leighton CE, Bouffard A, Dropinski JF, Balkovec J: In vitro<\/I> preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother 41: 2326-2332, 1997.","DOI":"10.1128\/AAC.41.11.2326"},{"key":"19","doi-asserted-by":"crossref","unstructured":"21) Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, Goto T, Tomishima M, Ohki H, Yamada A, Kawabata K, Takasugi H, Sakane K, Tanaka H, Matsumoto F, Kuwahara S: In vitro<\/I> activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 44: 57-62, 2000.","DOI":"10.1128\/AAC.44.1.57-62.2000"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22) Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM: The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro<\/I>. Antimicrob Agents Chemother 46: 3001-3012, 2002.","DOI":"10.1128\/AAC.46.9.3001-3012.2002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23) Watabe E, Nakai T, Matsumoto S, Ikeda F, Hatano K: Killing activity of micafungin against Aspergillus fumigatus<\/I> hyphae assessed by specific fluorescent staining for cell viability. Antimicrob Agents Chemother 47: 1995-1998, 2003.","DOI":"10.1128\/AAC.47.6.1995-1998.2003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"24) Douglas CM, Foor F, Marrinan JA, Morin N, Nielsen JB, Dahl AM, Mazur P, Baginsky W, Li W, el-Sherbeini M, Clemas JA, Mandala SM, Frommer BR, Kurtz MB: The Saccharomyces cerevisiae FKS1<\/I> (ETG1<\/I>) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. Proc Natl Acad Sci U S A 91: 12907-12911, 1994.","DOI":"10.1073\/pnas.91.26.12907"},{"key":"23","doi-asserted-by":"crossref","unstructured":"25) Qadota H, Python CP, Inoue SB, Arisawa M, Anraku Y, Zheng Y, Watanabe T, Levin DE, Ohya Y: Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan synthase. Science 272: 279-281, 1996.","DOI":"10.1126\/science.272.5259.279"},{"key":"24","doi-asserted-by":"crossref","unstructured":"26) Parent SA, Nielsen JB, Morin N, Chrebet G, Ramadan N, Dahl AM, Hsu MJ, Bostian KA, Foor F: Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae<\/I>. J Gen Microbiol 139: 2973-2984, 1993.","DOI":"10.1099\/00221287-139-12-2973"},{"key":"25","doi-asserted-by":"crossref","unstructured":"27) Douglas CM, Marrinan JA, Li W, Kurtz MB: A Saccharomyces cerevisiae<\/I> mutant with echinocandin-resistant 1,3-beta-D-glucan synthase. J Bacteriol 176: 5686-5696, 1994.","DOI":"10.1128\/jb.176.18.5686-5696.1994"},{"key":"26","doi-asserted-by":"crossref","unstructured":"28) Mazur P, Morin N, Baginsky W, el-Sherbeini M, Clemas JA, Nielsen JB, Foor F: Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. Mol Cell Biol 15: 5671-5681, 1995.","DOI":"10.1128\/MCB.15.10.5671"},{"key":"27","doi-asserted-by":"crossref","unstructured":"29) Ishihara S, Hirata A, Nogami S, Beauvais A, Latge JP, Ohya Y: Homologous subunits of 1,3-beta-glucan synthase are important for spore wall assembly in Saccharomyces cerevisiae<\/I>. Eukaryot Cell 6: 143-156, 2007.","DOI":"10.1128\/EC.00200-06"},{"key":"28","doi-asserted-by":"crossref","unstructured":"30) Kurtz MB, Abruzzo G, Flattery A, Bartizal K, Marrinan JA, Li W, Milligan J, Nollstadt K, Douglas CM: Characterization of echinocandin-resistant mutants of Candida albicans<\/I>: genetic, biochemical, and virulence studies. Infect Immun 64: 3244-3251, 1996.","DOI":"10.1128\/IAI.64.8.3244-3251.1996"},{"key":"29","doi-asserted-by":"crossref","unstructured":"31) Douglas CM, D’Ippolito JA, Shei GJ, Meinz M, Onishi J, Marrinan JA, Li W, Abruzzo GK, Flattery A, Bartizal K, Mitchell A, Kurtz MB: Identification of the FKS1<\/I> gene of Candida albicans<\/I> as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 41: 2471-2479, 1997.","DOI":"10.1128\/AAC.41.11.2471"},{"key":"30","doi-asserted-by":"crossref","unstructured":"32) Park S, Kelly R, Kahn JN, et al: Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida<\/I> sp. isolates. Antimicrob Agents Chemother 49: 3264-3273, 2005.","DOI":"10.1128\/AAC.49.8.3264-3273.2005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"33) Perlin DS: Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10: 121-130, 2007.","DOI":"10.1016\/j.drup.2007.04.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"34) Eng WK, Faucette L, McLaughlin MM, Cafferkey R, Koltin Y, Morris RA, Young PR, Johnson RK, Livi GP: The yeast FKS1<\/I> gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. Gene 151: 61-71, 1994.","DOI":"10.1016\/0378-1119(94)90633-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"35) Mio T, Adachi-Shimizu M, Tachibana Y, Tabuchi H, Inoue SB, Yabe T, Yamada-Okabe T, Arisawa M, Watanabe T, Yamada-Okabe H: Cloning of the Candida albicans<\/I> homolog of Saccharomyces cerevisiae GSC1\/FKS1<\/I> and its involvement in beta-1,3-glucan synthesis. J Bacteriol 179: 4096-4105, 1997.","DOI":"10.1128\/jb.179.13.4096-4105.1997"},{"key":"34","doi-asserted-by":"crossref","unstructured":"36) Katiyar S, Pfaller M, Edlind T. Candida albicans<\/I> and Candida glabrata<\/I> clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother 50: 2892-2894, 2006.","DOI":"10.1128\/AAC.00349-06"},{"key":"35","doi-asserted-by":"crossref","unstructured":"37) Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS: Caspofungin-resistant Candida tropicalis<\/I> strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother 52: 4181-4183, 2008.","DOI":"10.1128\/AAC.00802-08"},{"key":"36","doi-asserted-by":"crossref","unstructured":"38) Kahn JN, Garcia-Effron G, Hsu MJ, Park S, Marr KA, Perlin DS: Acquired echinocandin resistance in a Candida krusei<\/I> isolate due to modification of glucan synthase. Antimicrob Agents Chemother 51: 1876-1878, 2007.","DOI":"10.1128\/AAC.00067-07"},{"key":"37","doi-asserted-by":"crossref","unstructured":"39) Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS: Echinocandin susceptibility testing of Candida<\/I> species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother 54: 426-439, 2010.","DOI":"10.1128\/AAC.01256-09"},{"key":"38","doi-asserted-by":"crossref","unstructured":"40) León M, Sentandreu R, Zueco J: A single FKS<\/I> homologue in Yarrowia lipolytica<\/I> is essential for viability. Yeast 19: 1003-1014, 2002.","DOI":"10.1002\/yea.893"},{"key":"39","doi-asserted-by":"crossref","unstructured":"41) Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS: A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis<\/I>, Candida orthopsilosis<\/I>, and Candida metapsilosis<\/I> accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52: 2305-2312, 2008.","DOI":"10.1128\/AAC.00262-08"},{"key":"40","doi-asserted-by":"crossref","unstructured":"42) Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, Nguyen S, Leblond V, Mazier D, Datry A: Rapid emergence of echinocandin resistance during Candida kefyr<\/I> fungemia treatment with caspofungin. Antimicrob Agents Chemother 57: 2380-2382, 2013.","DOI":"10.1128\/AAC.02037-12"},{"key":"41","doi-asserted-by":"crossref","unstructured":"43) Desnos-Ollivier M, Moquet O, Chouaki T, Guérin AM, Dromer F: Development of echinocandin resistance in Clavispora lusitaniae<\/I> during caspofungin treatment. J Clin Microbiol 49: 2304-2306, 2011.","DOI":"10.1128\/JCM.00325-11"},{"key":"42","doi-asserted-by":"crossref","unstructured":"44) Dudiuk C, Macedo D, Leonardelli F, Theill L, Cabeza MS, Gamarra S, Garcia-Effron G: Molecular confirmation of the relationship between Candida guilliermondii<\/I> Fks1p naturally occurring amino acid substitutions and its intrinsic reduced echinocandin susceptibility. Antimicrob Agents Chemother 61: e02644-16, 2017.","DOI":"10.1128\/AAC.02644-16"},{"key":"43","doi-asserted-by":"crossref","unstructured":"45) Kelly R, Register E, Hsu MJ, Kurtz M, Nielsen J: Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans<\/I> and purification of the corresponding protein. J Bacteriol 178: 4381-4391, 1996.","DOI":"10.1128\/jb.178.15.4381-4391.1996"},{"key":"44","doi-asserted-by":"crossref","unstructured":"46) Beauvais A, Bruneau JM, Mol PC, Buitrago MJ, Legrand R, Latgé JP: Glucan synthase complex of Aspergillus fumigatus<\/I>. J Bacteriol 183: 2273-2279, 2001.","DOI":"10.1128\/JB.183.7.2273-2279.2001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"47) Staab JF, Kahn JN, Marr KA: Differential Aspergillus lentulus<\/I> echinocandin susceptibilities are Fksp independent. Antimicrob Agents Chemother 54: 4992-4998, 2010.","DOI":"10.1128\/AAC.00774-10"},{"key":"46","doi-asserted-by":"crossref","unstructured":"48) Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, Yuan X, Rude TH, Toffaletti DL, Perfect JR, Kurtz M: A glucan synthase FKS1<\/I> homolog in Cryptococcus neoformans<\/I> is single copy and encodes an essential function. J Bacteriol 181: 444-453, 1999.","DOI":"10.1128\/JB.181.2.444-453.1999"},{"key":"47","doi-asserted-by":"crossref","unstructured":"49) Yang RY, Li HT, Zhu H, Zhou GP, Wang M, Wang L: Genome sequence of the Trichosporon asahii<\/I> environmental strain CBS 8904. Eukaryot Cell 11: 1586-1587, 2012.","DOI":"10.1128\/EC.00264-12"},{"key":"48","doi-asserted-by":"crossref","unstructured":"50) Ha YS, Covert SF, Momany M: FsFKS1<\/I>, the 1,3-beta-glucan synthase from the caspofungin-resistant fungus Fusarium solani<\/I>. Eukaryot Cell 5: 1036-1042, 2006.","DOI":"10.1128\/EC.00030-06"},{"key":"49","doi-asserted-by":"crossref","unstructured":"51) Katiyar SK, Edlind TD: Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani<\/I> as evidenced by hybrid expression in Saccharomyces cerevisiae<\/I>. Antimicrob Agents Chemother 53: 1772-1778, 2009.","DOI":"10.1128\/AAC.00020-09"},{"key":"50","doi-asserted-by":"crossref","unstructured":"52) Anjos J, Fernandes C, Silva BM, Quintas C, Abrunheiro A, Gow NA, Gonçalves T: β(1,3)-glucan synthase complex from Alternaria infectoria<\/I>, a rare dematiaceous human pathogen. Med Mycol 50: 716-725, 2012.","DOI":"10.3109\/13693786.2012.675525"},{"key":"51","doi-asserted-by":"crossref","unstructured":"53) Pereira M, Felipe MS, Brígido MM, Soares CM, Azevedo MO: Molecular cloning and characterization of a glucan synthase gene from the human pathogenic fungus Paracoccidioides brasiliensis<\/I>. Yeast 16: 451-462, 2000.","DOI":"10.1002\/(SICI)1097-0061(20000330)16:5<451::AID-YEA540>3.0.CO;2-O"},{"key":"52","doi-asserted-by":"crossref","unstructured":"54) Kellner EM, Orsborn KI, Siegel EM, Mandel MA, Orbach MJ, Galgiani JN: Coccidioides posadasii<\/I> contains a single 1,3-beta-glucan synthase gene that appears to be essential for growth. Eukaryot Cell 4: 111-120, 2005.","DOI":"10.1128\/EC.4.1.111-120.2005"},{"key":"53","doi-asserted-by":"crossref","unstructured":"55) Kottom TJ, Limper AH: Cell wall assembly by Pneumocystis carinii<\/I>. Evidence for a unique gsc-1 subunit mediating beta-1,3-glucan deposition. J Biol Chem 275: 40628-40634, 2000.","DOI":"10.1074\/jbc.M002103200"},{"key":"54","unstructured":"56) Espinel-Ingroff A: In vitro<\/I> antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 20: 121-136, 2003."},{"key":"55","doi-asserted-by":"crossref","unstructured":"57) Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ: In vitro<\/I> susceptibility of invasive isolates of Candida<\/I> spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46: 150-156, 2008.","DOI":"10.1128\/JCM.01901-07"},{"key":"56","doi-asserted-by":"crossref","unstructured":"58) Lockhart SR, Messer SA, Pfaller MA, Diekema DJ: Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis<\/I> and Candida metapsilosis<\/I> in comparison to the closely related species Candida parapsilosis<\/I>. J Clin Microbiol 46: 2659-2664, 2008.","DOI":"10.1128\/JCM.00803-08"},{"key":"57","doi-asserted-by":"crossref","unstructured":"59) Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T: In vitro<\/I> echinocandin susceptibility of Aspergillus<\/I> isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother 55: 3944-3946, 2011.","DOI":"10.1128\/AAC.00428-11"},{"key":"58","doi-asserted-by":"crossref","unstructured":"60) Franzot SP, Casadevall A: Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro<\/I>. Antimicrob Agents Chemother 41: 331-336, 1997.","DOI":"10.1128\/AAC.41.2.331"},{"key":"59","doi-asserted-by":"crossref","unstructured":"61) Trilles L, Fernández-Torres B, Lazéra Mdos S, Wanke B, Guarro J: In vitro<\/I> antifungal susceptibility of Cryptococcus gattii<\/I>. J Clin Microbiol 42: 4815-4817, 2004.","DOI":"10.1128\/JCM.42.10.4815-4817.2004"},{"key":"60","doi-asserted-by":"crossref","unstructured":"62) Maligie MA, Selitrennikoff CP: Cryptococcus neoformans<\/I> resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother 49: 2851-2856, 2005.","DOI":"10.1128\/AAC.49.7.2851-2856.2005"},{"key":"61","doi-asserted-by":"crossref","unstructured":"63) Huang W, Liao G, Baker GM, Wang Y, Lau R, Paderu P, Perlin DS, Xue C: Lipid flippase subunit Cdc50 mediates drug resistance and virulence in Cryptococcus neoformans<\/I>. MBio 7: e00478-16, 2016.","DOI":"10.1128\/mBio.00478-16"},{"key":"62","doi-asserted-by":"crossref","unstructured":"64) Toh-E A, Ohkusu M, Shimizu K, Yamaguchi M, Ishiwada N, Watanabe A, Kamei K: Creation, characterization and utilization of Cryptococcus neoformans<\/I> mutants sensitive to micafungin. Curr Genet 63: 1093-1104, 2017.","DOI":"10.1007\/s00294-017-0713-8"},{"key":"63","doi-asserted-by":"crossref","unstructured":"65) Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K, Kawai T: Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345: 17-20, 1995.","DOI":"10.1016\/S0140-6736(95)91152-9"},{"key":"64","doi-asserted-by":"crossref","unstructured":"66) Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF: Species-specific antifungal susceptibility patterns of Scedosporium<\/I> and Pseudallescheria<\/I> species. Antimicrob Agents Chemother 56: 2635-2642, 2012.","DOI":"10.1128\/AAC.05910-11"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67) Johnson ME, Katiyar SK, Edlind TD: New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae<\/I> and its contribution to intrinsic resistance of Scedosporium<\/I> species. Antimicrob Agents Chemother 55: 3774-3781, 2011.","DOI":"10.1128\/AAC.01811-10"},{"key":"66","doi-asserted-by":"crossref","unstructured":"68) Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE Jr, Douglas CM: Caspofungin inhibits Rhizopus oryzae<\/I> 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 49: 721-727, 2005.","DOI":"10.1128\/AAC.49.2.721-727.2005"},{"key":"67","doi-asserted-by":"crossref","unstructured":"69) Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M: In vitro<\/I> antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 47: 1376-1381, 2003.","DOI":"10.1128\/AAC.47.4.1376-1381.2003"},{"key":"68","doi-asserted-by":"crossref","unstructured":"70) Espinel-Ingroff A: Comparison of in vitro<\/I> activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 36: 2950-2956, 1998.","DOI":"10.1128\/JCM.36.10.2950-2956.1998"},{"key":"69","doi-asserted-by":"crossref","unstructured":"71) Kohler S, Wheat LJ, Connolly P, Schnizlein-Bick C, Durkin M, Smedema M, Goldberg J, Brizendine E: Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother 44: 1850-1854, 2000.","DOI":"10.1128\/AAC.44.7.1850-1854.2000"},{"key":"70","doi-asserted-by":"crossref","unstructured":"72) Kanetsuna F, Carbonell LM, Azuma I, Yamamura Y: Biochemical studies on the thermal dimorphism of Paracoccidioides brasiliensis<\/I>. J Bacteriol 110: 208-218, 1972.","DOI":"10.1128\/JB.110.1.208-218.1972"},{"key":"71","doi-asserted-by":"crossref","unstructured":"73) Domer JE: Monosaccharide and chitin content of cell walls of Histoplasma capsulatum<\/I> and Blastomyces dermatitidis<\/I>. J Bacteriol 107: 870-877, 1971.","DOI":"10.1128\/JB.107.3.870-877.1971"},{"key":"72","doi-asserted-by":"crossref","unstructured":"74) Kanetsuna F, Carbonell LM: Cell wall composition of the yeastlike and mycelia forms of Blastomyces dermatitidis<\/I>. J Bacteriol 106: 946-948, 1971.","DOI":"10.1128\/JB.106.3.946-948.1971"},{"key":"73","doi-asserted-by":"crossref","unstructured":"75) Galgiani JN, Sun SH, Clemons KV, Stevens DA: Activity of cilofungin against Coccidioides immitis<\/I>: differential in vitro<\/I> effects on mycelia and spherules correlated with in vivo<\/I> studies. J Infect Dis 162: 944-948, 1990.","DOI":"10.1093\/infdis\/162.4.944"},{"key":"74","doi-asserted-by":"crossref","unstructured":"76) Cushion MT, Collins MS: Susceptibility of Pneumocystis<\/I> to echinocandins in suspension and biofilm cultures. Antimicrob Agents Chemother 55: 4513-4518, 2011.","DOI":"10.1128\/AAC.00017-11"},{"key":"75","doi-asserted-by":"crossref","unstructured":"77) Powles MA, Liberator P, Anderson J, Karkhanis Y, Dropinski JF, Bouffard FA, Balkovec JM, Fujioka H, Aikawa M, McFadden D, Schmatz D: Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii<\/I>. Antimicrob Agents Chemother 42: 1985-1989, 1998.","DOI":"10.1128\/AAC.42.8.1985"},{"key":"76","doi-asserted-by":"crossref","unstructured":"78) Ito M, Nozu R, Kuramochi T, Eguchi N, Suzuki S, Hioki K, Itoh T, Ikeda F: Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii<\/I> infection in mice. Antimicrob Agents Chemother 44: 2259-2262, 2000.","DOI":"10.1128\/AAC.44.9.2259-2262.2000"},{"key":"77","doi-asserted-by":"crossref","unstructured":"79) Annaloro C, Della Volpe A, Usardi P, Lambertenghi Deliliers G: Caspofungin treatment of Pneumocystis<\/I> pneumonia during conditioning for bone marrow transplantation. Eur J Clin Microbiol Infect Dis 25: 52-54, 2006.","DOI":"10.1007\/s10096-005-0065-z"},{"key":"78","doi-asserted-by":"crossref","unstructured":"80) Hof H, Schnülle P: Pneumocystis jiroveci<\/I> pneumonia in a patient with Wegener’s granulomatosis treated efficiently with caspofungin. Mycoses 51 (Suppl 1): 65-67, 2008.","DOI":"10.1111\/j.1439-0507.2008.01530.x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"81) Nollstadt KH, Powles MA, Fujioka H, Aikawa M, Schmatz DM: Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii<\/I> and effects of pneumocandin B0 analog L-733,560. Antimicrob Agents Chemother 38: 2258-2265, 1994.","DOI":"10.1128\/AAC.38.10.2258"},{"key":"80","doi-asserted-by":"crossref","unstructured":"82) Castanheira M, Woosley LN, Diekema DJ, Messer SA, Jones RN, Pfaller MA: Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida<\/I> strains. Antimicrob Agents Chemother 54: 2655-2659, 2010.","DOI":"10.1128\/AAC.01711-09"},{"key":"81","doi-asserted-by":"crossref","unstructured":"83) Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA: Increasing echinocandin resistance in Candida glabrata<\/I>: clinical failure correlates with presence of FKS<\/I> mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56: 1724-1732, 2013.","DOI":"10.1093\/cid\/cit136"},{"key":"82","doi-asserted-by":"crossref","unstructured":"84) Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN: Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata<\/I>. J Clin Microbiol 50: 1199-1203, 2012.","DOI":"10.1128\/JCM.06112-11"},{"key":"83","doi-asserted-by":"crossref","unstructured":"85) Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DS: Prevalent mutator genotype identified in fungal pathogen Candida glabrata<\/I> promotes multi-drug resistance. Nat Commun 7: 11128, 2016.","DOI":"10.1038\/ncomms11128"},{"key":"84","doi-asserted-by":"crossref","unstructured":"86) Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E; European Committee on Antibiotic Susceptibility Testing: Mutations in the fks1<\/I> gene in Candida albicans<\/I>, C. tropicalis<\/I>, and C. krusei<\/I> correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 52: 3092-3098, 2008.","DOI":"10.1128\/AAC.00088-08"},{"key":"85","doi-asserted-by":"crossref","unstructured":"87) Jensen RH, Johansen HK, Arendrup MC: Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis<\/I>. Antimicrob Agents Chemother 57: 614-617, 2013.","DOI":"10.1128\/AAC.01193-12"},{"key":"86","doi-asserted-by":"crossref","unstructured":"88) Prigent G, Aït-Ammar N, Levesque E, Fekkar A, Costa JM, El Anbassi S, Foulet F, Duvoux C, Merle JC, Dannaoui E, Botterel F: Echinocandin resistance in Candida<\/I> species isolates from liver transplant recipients. Antimicrob Agents Chemother 61: e01229-16, 2017.","DOI":"10.1128\/AAC.01229-16"},{"key":"87","doi-asserted-by":"crossref","unstructured":"89) Staab JF, Neofytos D, Rhee P, Jiménez-Ortigosa C, Zhang SX, Perlin DS, Marr KA: Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr<\/I>. Antimicrob Agents Chemother 58: 5421-5427, 2014.","DOI":"10.1128\/AAC.00096-14"},{"key":"88","doi-asserted-by":"crossref","unstructured":"90) Asner SA, Giulieri S, Diezi M, Marchetti O, Sanglard D: Acquired multidrug antifungal resistance in Candida lusitaniae<\/I> during therapy. Antimicrob Agents Chemother 59: 7715-7722, 2015.","DOI":"10.1128\/AAC.02204-15"},{"key":"89","doi-asserted-by":"crossref","unstructured":"91) Perlin DS: Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs 74: 1573-1585, 2014.","DOI":"10.1007\/s40265-014-0286-5"},{"key":"90","doi-asserted-by":"crossref","unstructured":"92) Garcia-Effron G, Park S, Perlin DS: Correlating echinocandin MIC and kinetic inhibition of fks1<\/I> mutant glucan synthases for Candida albicans<\/I>: implications for interpretive breakpoints. Antimicrob Agents Chemother 53: 112-122, 2009.","DOI":"10.1128\/AAC.01162-08"},{"key":"91","doi-asserted-by":"crossref","unstructured":"93) Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS: Effect of Candida glabrata FKS1<\/I> and FKS2<\/I> mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53: 3690-3699, 2009.","DOI":"10.1128\/AAC.00443-09"},{"key":"92","doi-asserted-by":"crossref","unstructured":"94) Perlin DS: Current perspectives on echinocandin class drugs. Future Microbiol 6: 441-457, 2011.","DOI":"10.2217\/fmb.11.19"},{"key":"93","doi-asserted-by":"crossref","unstructured":"95) Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ: The presence of an FKS<\/I> mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata<\/I>. Antimicrob Agents Chemother 56: 4862-4869, 2012.","DOI":"10.1128\/AAC.00027-12"},{"key":"94","doi-asserted-by":"crossref","unstructured":"96) Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS: Emergence of echinocandin resistance due to a point mutation in the fks1<\/I> gene of Aspergillus fumigatus<\/I> in a patient with chronic pulmonary aspergillosis. Antimicrob Agents Chemother 61: e01277-17, 2017.","DOI":"10.1128\/AAC.01277-17"},{"key":"95","doi-asserted-by":"crossref","unstructured":"97) Patterson TF, Thompson GR 3rd, Denning DW, et al: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63: e1-e60, 2016.","DOI":"10.1093\/cid\/ciw326"},{"key":"96","doi-asserted-by":"crossref","unstructured":"98) Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C, Herbrecht R: ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 102: 433-444, 2017.","DOI":"10.3324\/haematol.2016.152900"},{"key":"97","doi-asserted-by":"crossref","unstructured":"99) Fernández-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, Montejo M, García-Rodríguez J, Pemán J, Ruiz Pérez de Pipaón M, Cuenca-Estrella M; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI: Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis<\/I> bloodstream infection: a propensity score analysis. Clin Infect Dis 58: 1413-1421, 2014.","DOI":"10.1093\/cid\/ciu158"},{"key":"98","doi-asserted-by":"crossref","unstructured":"100) Mardini J, Nguyen B, Ghannoum M, Couture C, Lavergne V: Treatment of chronic pulmonary blastomycosis with caspofungin. J Med Microbiol 60: 1875-1878, 2011.","DOI":"10.1099\/jmm.0.036103-0"},{"key":"99","doi-asserted-by":"crossref","unstructured":"101) Levy ER, McCarty JM, Shane AL, Weintrub PS: Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis 56: 1573-1578, 2013.","DOI":"10.1093\/cid\/cit113"},{"key":"100","doi-asserted-by":"crossref","unstructured":"102) Ogawa T, Takezawa K, Tojima I, Shibayama M, Kouzaki H, Ishida M, Okabe H, Shimizu T: Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin. Auris Nasus Larynx 39: 224-228, 2012.","DOI":"10.1016\/j.anl.2011.03.006"},{"key":"101","doi-asserted-by":"crossref","unstructured":"103) Kazak E, Aslan E, Akalin H, Saraydaroglu O, Hakyemez B, Erisen L, Yazici B, Gürcüoglu E, Yilmaz E, Ener B, Helvaci S: A mucormycosis case treated with a combination of caspofungin and amphotericin B. J Mycol Med 23: 179-184, 2013.","DOI":"10.1016\/j.mycmed.2013.06.003"},{"key":"102","doi-asserted-by":"crossref","unstructured":"104) Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, Kolbin AS, Medvedeva NV, Zuzgin IS, Simkin SM, Vasilyeva NV, Afanasiev BV: Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia. Mycoses 57 (Suppl 3): 91-96, 2014.","DOI":"10.1111\/myc.12247"},{"key":"103","doi-asserted-by":"crossref","unstructured":"105) Cornely OA, Arikan-Akdagli S, Dannaoui E, et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20: 5-26, 2014.","DOI":"10.1111\/1469-0691.12371"},{"key":"104","doi-asserted-by":"crossref","unstructured":"106) Jiménez-Ortigosa C, Paderu P, Motyl MR, Perlin DS: Enfumafungin derivative MK-3118 shows increased in vitro<\/I> potency against clinical echinocandin-resistant Candida<\/I> species and Aspergillus<\/I> species isolates. Antimicrob Agents Chemother 58: 1248-51, 2014.","DOI":"10.1128\/AAC.02145-13"},{"key":"105","doi-asserted-by":"crossref","unstructured":"107) Pfaller MA, Messer SA, Rhomberg PR, Borroto-Esoda K, Castanheira M: Differential activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida<\/I> species. Antimicrob Agents Chemother 61: e00161-17, 2017.","DOI":"10.1128\/AAC.00161-17"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/59\/2\/59_18.004\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T22:03:43Z","timestamp":1604354623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/59\/2\/59_18.004\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.18.004","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}